Echinaforce Chewable tablets

DRUG2 trials

Sponsors

A. Vogel AG

Conditions

COVID-19 Respiratory InfectionCommon ColdRespiratory Tract InfectionsSARS-CoV2 Infection

Phase 4

Echinaforce COVID-19 Shedding Study

TerminatedNCT04999098

A. Vogel AGCOVID-19 Respiratory Infection, SARS-CoV2 Infection

Start: 2021-11-15End: 2023-08-15Updated: 2024-08-06

Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections

CompletedNCT05002179

A. Vogel AGCommon Cold, Respiratory Tract Infections

Start: 2020-11-20End: 2021-05-29Updated: 2021-08-12